Federal Agency Wants Public’s Help Finding Research On Medical MJ For Pain And Migraines
Marijuana Stocks, Finance, & InvestingUncategorized January 22, 2020 MJ Shareholders
A federal agency is asking the public to submit scientific data on the potential benefits of marijuana for people with acute pain and migraine headaches.
In two notices published in the Federal Register this month, the Agency for Healthcare Research and Quality (AHRQ) said it is conducting a review of treatment approaches to the two health conditions, with a particular focus on alternatives to opioids. Both listings specifically include cannabis as an example of a therapy the government would like help investigating.
The agency, which is a division of the Department of Health and Human Services, said it “is dedicated to identifying as many studies as possible that are relevant to the questions for each of its reviews.”
“In order to do so, we are supplementing the usual manual and electronic database searches of the literature by requesting information from the public (e.g., details of studies conducted).”
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
